Mass Production of Pharmaceutical Blister Aluminum Films: Solvent-Free PU Lamination Adhesives Meet Medical Cleanliness Standards Wholesale

Products

Mass Production of Pharmaceutical Blister Aluminum Films: Solvent-Free PU Lamination Adhesives Meet Medical Cleanliness Standards

Pharmaceutical blister aluminum film packaging is the primary safety barrier for tablets, capsules and other solid oral medicines, directly determining drug stability, shelf life and clinical medication safety. As the global pharmaceutical industry upgrades clean production and standardized packaging, traditional blister packaging lamination processes can no longer meet stringent medical-grade cleanliness requirements. Thanks to its zero-pollution characteristics and stable lamination performance, solvent-free polyurethane (PU) lamination adhesives have achieved large-scale mass application in pharmaceutical blister aluminum film production, becoming a core material that conforms to high-standard medical packaging specifications.
Medical packaging differs fundamentally from food packaging, with zero tolerance for impurities, solvent residues and harmful substance migration. Pharmaceutical blister aluminum foil requires production and lamination in dust-free clean workshops to avoid secondary contamination of drugs. Traditional solvent-based adhesives contain volatile organic compounds (VOCs). During high-speed lamination production, solvent volatilization will generate tiny pollutant particles, which easily adhere to aluminum film surfaces, failing cleanroom production standards. Moreover, residual solvents may slowly migrate during drug storage, triggering ingredient deterioration and affecting medication safety.
Solvent-free PU lamination adhesives completely solve the cleanliness pain points of medical packaging production with their 100% solid-content solvent-free formula. The full reactive curing process produces no VOC emissions, no peculiar odor and no particulate pollutants, fully adapting to Class 300,000 and above medical clean workshop production environments. Without any toxic and harmful additives, the adhesive forms a dense, smooth and inert adhesive layer after complete curing, achieving flawless lamination between aluminum foil and medical-grade plastic substrates such as PVC and PVDC.
In addition to superior clean production adaptability, the material delivers ultra-stable composite performance suitable for pharmaceutical packaging. It features uniform bonding strength and excellent aging resistance, avoiding delamination, bubbling and cracking of blister aluminum films during long-term drug storage and conventional temperature and humidity changes. Its dense molecular structure provides excellent barrier performance, effectively isolating moisture, oxygen and external pollutants, preventing drug deliquescence, oxidation and efficacy attenuation, and greatly extending the validity period of pharmaceuticals.
In terms of medical safety compliance, the adhesive passes strict global pharmaceutical packaging certification. It fully meets FDA 21 CFR medical material specifications, EU GMP clean production standards and China’s YBB pharmaceutical packaging safety norms. With ultra-low extractable and leachable substances, it will not chemically react with drug ingredients, ensuring the purity and safety of packaged medicines, which fully matches the stringent requirements of primary pharmaceutical packaging materials.
Industry insiders stated that medical packaging cleanliness and safety are the bottom-line requirements of pharmaceutical production. The large-scale implementation of solvent-free PU lamination technology has standardized the production process of pharmaceutical blister aluminum films, eliminated potential safety hazards of traditional processes, and promoted the iterative upgrading of medical composite packaging.
As global pharmaceutical supervision becomes increasingly rigorous, clean, safe and stable packaging materials will become the mainstream of the industry. Solvent-free polyurethane lamination adhesives will continue to expand their application in medical packaging scenarios, providing reliable technical support for standardized mass production of pharmaceutical blister packaging and safeguarding global drug safety.

Submit feedback